Regeneron Partly Agrees It Infringed COVID Tech Patent
Regeneron Pharmaceuticals Inc. has agreed in part that it infringed a California company's patent when developing and testing COVID-19 vaccines and treatments, although it maintained that any liability it may have...To view the full article, register now.
Already a subscriber? Click here to view full article